Corporate policy or CEO activism? Citigroup’s stance on reproductive healthcare in the USA

Abstract

Research methodology

The case and supporting teaching note were developed through the use of secondary sources such as company documents and archives, news articles and academic publications.

Case overview/synopsis

Jane Fraser, Citigroup CEO and the first woman to lead a major Wall Street bank, found herself at a crossroads. Weeks prior to the company’s 2022 annual shareholder meeting, Citigroup announced it would provide reproductive health-care benefits to employees traveling out of state for an abortion. Prompted by legal developments that hinted at the potential for a widespread ban on abortions, the announcement resulted in threats from Republican lawmakers to change course or suffer financial consequences. Through the case, students explore the role of business and corporate leadership in response to controversial political issues, including the potential opportunities and threats.

Complexity academic level

The case is best-suited for management or other business students at the undergraduate or graduate/MBA level. The learning objectives of the case would fit well within any of the following courses: Corporate Social Responsibility (CSR)/Business and Society; Business Ethics and Decision-Making; and Strategic Management. Instructors should position the case after students have been introduced to the topic of corporate social responsibility, ethical decision-making and/or CEO activism.

Citation

Holtzen, S., Williamson, A., Sherman, K., Douglas, M. and Ruane, S.G. (2024), "Corporate policy or CEO activism? Citigroup’s stance on reproductive healthcare in the USA", , Vol. 20 No. 6, pp. 1398-1422. https://doi.org/10.1108/TCJ-04-2023-0066